A separate study out of England retrospectively evaluated a telemedical model whereby patients with a history of exudative AMD requiring anti-VEGF injections but with recent stability not requiring treatment underwent visual acuity testing and OCT scans of the macula during a hybrid in-person testing visit without real-time in-person physician evaluation [15]. The gene discussed is VEGFA; the disease is age-related macular degeneration.